SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-014844
Filing Date
2022-03-24
Accepted
2022-03-24 16:07:42
Documents
60
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_tffpharma.htm   iXBRL 10-K 1717631
2 CONSENT OF MARCUM LLP f10k2021ex23-1_tffpharma.htm EX-23.1 2488
3 CERTIFICATION f10k2021ex31-1_tffpharma.htm EX-31.1 19595
4 CERTIFICATION f10k2021ex31-2_tffpharma.htm EX-31.2 19466
5 CERTIFICATION f10k2021ex32-1_tffpharma.htm EX-32.1 12960
6 GRAPHIC img_001.jpg GRAPHIC 5343
7 GRAPHIC img_002.jpg GRAPHIC 57669
  Complete submission text file 0001213900-22-014844.txt   5509353

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE tffp-20211231.xsd EX-101.SCH 56679
9 XBRL CALCULATION FILE tffp-20211231_cal.xml EX-101.CAL 20771
10 XBRL DEFINITION FILE tffp-20211231_def.xml EX-101.DEF 193086
11 XBRL LABEL FILE tffp-20211231_lab.xml EX-101.LAB 409806
12 XBRL PRESENTATION FILE tffp-20211231_pre.xml EX-101.PRE 207004
54 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_tffpharma_htm.xml XML 576634
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39102 | Film No.: 22766547
SIC: 2834 Pharmaceutical Preparations